Related Experiment Video
Updated: Jun 10, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Relationships between sleep duration and von Willebrand factor, factor VII, and fibrinogen: Whitehall II study
Michelle A Miller1, Ngianga-Bakwin Kandala, Meena Kumari
1University of Warwick, Clinical Sciences Research Institute, Warwick Medical School, UHCW Campus, Clifford Bridge Road, Coventry CV2 2DX, England. michelle.miller@warwick.ac.uk
Objective:
To examine the relationship between sleep duration and hemostatic factors in a well-characterized cohort.
Methods And Results:
The relationship between self-reported sleep duration and von Willebrand factor (vWF), fibrinogen, and factor VII was examined in approximately 6400 individuals from the Whitehall II Study. The analysis was stratified by sex (interaction P<0.001). After multiple adjustments, vWF levels were significantly higher in men with both short sleep duration (≤6 hours per night; 1.05 [95% CI, 1.01 to 1.08] [data given as geometric mean]) and long sleep duration (≥8 hours per night; 1.05 [95% CI, 1.02 to 1.08]) compared with those who slept 7 hours (P<0.05 for both). In women, levels of vWF were significantly higher in individuals who slept 8 hours or longer (1.11 [95% CI, 1.06 to 1.16]) compared with 7 hours (P<0.05). This difference was observed in premenopausal and postmenopausal women. In women, the association was nonlinear (P=0.02), but not in men (P=0.09). No statistically significant associations between sleep duration and fibrinogen or factor VII were observed.
Conclusions:
Men who slept for short and long durations had higher vWF levels. In women, there was a significant nonlinear association. The highest levels were observed in long sleepers, irrespective of menopausal status. No major associations between sleep and factor VII or fibrinogen were observed. Longitudinal studies are required to investigate causality.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Clot Retraction and Fibrinolysis
